Ågren A - Search Results

1

Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system.

Ågren A, Holmström M, Schmidt DE, Hosokawa K, Blombäck M, Hjemdahl P. Ågren A, et al. Thromb Haemost. 2017 Jan 5;117(1):75-85. doi: 10.1160/TH16-06-0430. Epub 2016 Oct 20. Thromb Haemost. 2017. PMID: 27761577

2

Evaluation of low PAI-1 activity as a risk factor for hemorrhagic diathesis.

Agren A, Wiman B, Stiller V, Lindmarker P, Sten-Linder M, Carlsson A, Holmström M, Odeberg J, Schulman S. Agren A, et al. J Thromb Haemost. 2006 Jan;4(1):201-8. doi: 10.1111/j.1538-7836.2005.01709.x. J Thromb Haemost. 2006. PMID: 16409470 Free article.

3

Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity.

Agren A, Wiman B, Schulman S. Agren A, et al. Blood Coagul Fibrinolysis. 2007 Oct;18(7):657-60. doi: 10.1097/MBC.0b013e3282dded21. Blood Coagul Fibrinolysis. 2007. PMID: 17890953

4

Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy.

Majeed A, Eelde A, Agren A, Schulman S, Holmström M. Majeed A, et al. Among authors: agren a. Thromb Res. 2012 Feb;129(2):146-51. doi: 10.1016/j.thromres.2011.07.024. Epub 2011 Jul 31. Thromb Res. 2012. PMID: 21807399

5

Studies of microparticles in patients with the antiphospholipid syndrome (APS).

Vikerfors A, Mobarrez F, Bremme K, Holmström M, Ågren A, Eelde A, Bruzelius M, Antovic A, Wallén H, Svenungsson E. Vikerfors A, et al. Among authors: agren a. Lupus. 2012 Jun;21(7):802-5. doi: 10.1177/0961203312437809. Lupus. 2012. PMID: 22635239

6

Thromboelastography (TEG®) compared to conventional coagulation tests in surgical patients--a laboratory evaluation.

Ågren A, Wikman AT, Holmström M, Östlund A, Edgren G. Ågren A, et al. Scand J Clin Lab Invest. 2013 Apr;73(3):214-20. doi: 10.3109/00365513.2013.765960. Epub 2013 Feb 12. Scand J Clin Lab Invest. 2013. PMID: 23402666

7

Studies of fibrin formation and fibrinolytic function in patients with the antiphospholipid syndrome.

Vikerfors A, Svenungsson E, Ågren A, Mobarrez F, Bremme K, Holmström M, Eelde A, Bruzelius M, Elgue G, Wallén H, Antovic A. Vikerfors A, et al. Among authors: agren a. Thromb Res. 2014 May;133(5):936-44. doi: 10.1016/j.thromres.2014.02.023. Epub 2014 Feb 28. Thromb Res. 2014. PMID: 24630645

8

Fibrin clot properties and haemostatic function in men and women with type 1 diabetes.

Tehrani S, Jörneskog G, Ågren A, Lins PE, Wallén H, Antovic A. Tehrani S, et al. Among authors: agren a. Thromb Haemost. 2015 Feb;113(2):312-8. doi: 10.1160/TH14-05-0404. Epub 2014 Oct 16. Thromb Haemost. 2015. PMID: 25318636

9

Detection of elevated INR by thromboelastometry and thromboelastography in warfarin treated patients and healthy controls.

Schmidt DE, Holmström M, Majeed A, Näslin D, Wallén H, Ågren A. Schmidt DE, et al. Among authors: agren a. Thromb Res. 2015 May;135(5):1007-11. doi: 10.1016/j.thromres.2015.02.022. Epub 2015 Feb 26. Thromb Res. 2015. PMID: 25746367

10

Strategies and outcomes of periprocedural bridging therapy with low-molecular-weight heparin in patients with mechanical heart valves.

Schulman JM, Majeed A, Mattsson E, Schulman S, Holmström M, Ågren A. Schulman JM, et al. Among authors: agren a. J Thromb Thrombolysis. 2015 Nov;40(4):430-6. doi: 10.1007/s11239-015-1216-4. J Thromb Thrombolysis. 2015. PMID: 25868460 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters